Results 21 to 30 of about 5,066,124 (300)

Overcoming TRAIL Resistance for Glioblastoma Treatment

open access: yesBiomolecules, 2021
The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) shows a promising therapeutic potential in cancer treatment as it exclusively causes apoptosis in a broad spectrum of cancer cells through triggering the extrinsic apoptosis ...
Longfei Deng   +3 more
doaj   +1 more source

Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines [PDF]

open access: yes, 2009
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis on binding to its receptors, death receptor 4 and 5 (DR4, DR5).
M Keane   +11 more
core   +1 more source

LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L

open access: yesNature Communications, 2018
TNF mediated inflammation is critical in autoimmune mediated pathology, however many patients are refractory to current anti-TNF therapeutics. Here the authors show induction of several death ligands, in addition to TNF is sufficient to cause fatal ...
Lucia Taraborrelli   +19 more
doaj   +1 more source

TRAIL/Apo-2L: Mechanisms and Clinical Applications in Cancer

open access: yesNeoplasia: An International Journal for Oncology Research, 2001
TNF-related apoptosis-inducing ligand (TRAIL/APO2L) is a member of the TNF family that promotes apoptosis by binding to the transmembrane receptors TRAIL-R1 /DR4 and TRAIL-R2/DR5.
Rakesh K. Srivastava
doaj   +1 more source

A Mechanism for Death Receptor Discrimination by Death Adaptors [PDF]

open access: yesJournal of Biological Chemistry, 2005
The death domain and death effector domain are two common motifs that mediate protein-protein interactions between components of cell death signaling complexes. The mechanism by which these domains engage their binding partners has been explored by extensive mutagenesis of two death adaptors, FADD and TRADD, suggesting that a death adaptor can ...
Cristinel, Sandu   +4 more
openaire   +2 more sources

Bid participates in genotoxic drug-induced apoptosis of HeLa cells and is essential for death receptor ligands' apoptotic and synergistic effects [PDF]

open access: yes, 2008
Background: The BH3-only protein Bid is an important component of death receptor-mediated caspase activation. Bid is cleaved by caspase-8 or -10 into t-Bid, which translocates to mitochondria and triggers the release of caspase-activating factors.
Caoimhin G Concannon   +17 more
core   +1 more source

Prostate cancer targeting using replication-selective adenoviruses in combination with phytochemicals [PDF]

open access: yes, 2009
PhD 2009 QMOncolytic adenoviral mutants have demonstrated good safety profiles but, despite some encouraging clinical results, efficacy as a single agent was limited. Combinations with conventional chemo- or radiotherapy significantly enhanced the anti-
Adam, Virginie Sarah
core   +4 more sources

Mechanisms of Apoptosis in the Ovary

open access: yesScientific Papers Animal Science and Biotechnologies, 2023
Of ovarian follicular reserve, only a small part of these follicles reach maturity, most of them suffering an involution process called follicular atresia.
Liliana Petculescu-Ciochina   +2 more
doaj  

Monte Carlo Study Elucidates the Type 1/Type 2 Choice in Apoptotic Death Signaling in Healthy and Cancer Cells

open access: yesCells, 2013
Apoptotic cell death is coordinated through two distinct (type 1 and type 2) intracellular signaling pathways. How the type 1/type 2 choice is made remains a central problem in the biology of apoptosis and has implications for apoptosis related diseases ...
Somkanya C Raychaudhuri   +1 more
doaj   +1 more source

Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5

open access: yesNeoplasia: An International Journal for Oncology Research, 2023
Recent studies indicate that signaling molecules traditionally associated with central nervous system function play critical roles in cancer. Dopamine receptor signaling is implicated in various cancers including glioblastoma (GBM) and it is a recognized
Hye-Min Jeon   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy